Cargando…
Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System
Angioedema is a potentially life-threatening adverse reaction to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. To study the genetic etiology of this rare adverse event, international consortia and multicenter recruitment of patients are needed. To reduce patient heterog...
Autores principales: | Wadelius, M, Marshall, S E, Islander, G, Nordang, L, Karawajczyk, M, Yue, Q-Y, Terreehorst, I, Baranova, E V, Hugosson, S, Sköldefors, K, Pirmohamed, M, Maitland-van der Zee, A-H, Alfirevic, A, Hallberg, P, Palmer, C N A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172548/ https://www.ncbi.nlm.nih.gov/pubmed/24960520 http://dx.doi.org/10.1038/clpt.2014.138 |
Ejemplares similares
-
Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
por: Rasmussen, Eva Rye, et al.
Publicado: (2020) -
Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker–Induced Angioedema
por: Maroteau, Cyrielle, et al.
Publicado: (2020) -
Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes
por: Mathey, Carina M., et al.
Publicado: (2022) -
Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema
por: Rasmussen, Eva Rye, et al.
Publicado: (2017) -
Corrigendum to “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema”
por: Rasmussen, Eva Rye, et al.
Publicado: (2018)